Dentsply International Inc. (XRAY) Position Reduced by Headinvest LLC
Headinvest LLC lowered its stake in shares of Dentsply International Inc. (NASDAQ:XRAY) by 0.5% during the second quarter, Holdings Channel reports. The fund owned 98,921 shares of the company’s stock after selling 455 shares during the period. Dentsply International comprises about 2.3% of Headinvest LLC’s portfolio, making the stock its 10th largest position. Headinvest LLC’s holdings in Dentsply International were worth $6,137,000 as of its most recent SEC filing.
A number of other hedge funds have also added to or reduced their stakes in the stock. Checchi Capital Advisers LLC raised its position in Dentsply International by 2.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,007 shares of the company’s stock valued at $125,000 after buying an additional 41 shares in the last quarter. Carnick & Kubik LLC purchased a new position in Dentsply International during the first quarter valued at approximately $201,000. Cacti Asset Management LLC purchased a new position in Dentsply International during the second quarter valued at approximately $203,000. Stratos Wealth Partners LTD. purchased a new position in Dentsply International during the first quarter valued at approximately $208,000. Finally, Trust Co. of Vermont raised its position in Dentsply International by 7.3% in the second quarter. Trust Co. of Vermont now owns 3,669 shares of the company’s stock valued at $227,000 after buying an additional 250 shares in the last quarter. Hedge funds and other institutional investors own 94.58% of the company’s stock.
Shares of Dentsply International Inc. (NASDAQ:XRAY) traded up 0.20% during midday trading on Thursday, reaching $60.01. 2,069,028 shares of the company’s stock were exchanged. The firm has a 50-day moving average of $60.68 and a 200-day moving average of $61.56. Dentsply International Inc. has a 1-year low of $49.48 and a 1-year high of $65.83. The company has a market capitalization of $13.98 billion, a PE ratio of 28.16 and a beta of 1.40.
Dentsply International (NASDAQ:XRAY) last issued its quarterly earnings data on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.70 by $0.06. The company earned $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The business’s revenue was up 46.4% on a year-over-year basis. During the same period last year, the business earned $0.73 earnings per share. Equities analysts expect that Dentsply International Inc. will post $2.76 earnings per share for the current fiscal year.
The business also recently disclosed a dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be issued a dividend of $0.0775 per share. The ex-dividend date is Wednesday, September 28th. Dentsply International’s payout ratio is presently 14.49%.
Several equities analysts have recently commented on the stock. JPMorgan Chase & Co. assumed coverage on shares of Dentsply International in a research report on Thursday. They set a “neutral” rating for the company. Bank of America Corp. started coverage on shares of Dentsply International in a research report on Monday, September 12th. They issued a “buy” rating and a $70.00 target price for the company. Jefferies Group reiterated a “buy” rating on shares of Dentsply International in a research report on Wednesday, August 17th. Zacks Investment Research lowered shares of Dentsply International from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Finally, Barrington Research lowered shares of Dentsply International from an “outperform” rating to a “market perform” rating in a research report on Monday, August 8th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $67.00.
In other news, SVP Maureen J. Macinnis sold 45,100 shares of the firm’s stock in a transaction on Thursday, August 25th. The stock was sold at an average price of $60.55, for a total value of $2,730,805.00. Following the completion of the sale, the senior vice president now directly owns 36,730 shares in the company, valued at $2,224,001.50. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Rainer Berthan sold 5,000 shares of the firm’s stock in a transaction on Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total value of $305,600.00. Following the completion of the sale, the vice president now owns 34,370 shares of the company’s stock, valued at $2,100,694.40. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.
About Dentsply International
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).
Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.